1. Home
  2. KDLY vs CERO Comparison

KDLY vs CERO Comparison

Compare KDLY & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KDLY
  • CERO
  • Stock Information
  • Founded
  • KDLY 2019
  • CERO 2017
  • Country
  • KDLY United States
  • CERO United States
  • Employees
  • KDLY N/A
  • CERO N/A
  • Industry
  • KDLY
  • CERO
  • Sector
  • KDLY
  • CERO
  • Exchange
  • KDLY NYSE
  • CERO Nasdaq
  • Market Cap
  • KDLY 7.8M
  • CERO 8.4M
  • IPO Year
  • KDLY 2024
  • CERO N/A
  • Fundamental
  • Price
  • KDLY $3.28
  • CERO $1.80
  • Analyst Decision
  • KDLY
  • CERO
  • Analyst Count
  • KDLY 0
  • CERO 0
  • Target Price
  • KDLY N/A
  • CERO N/A
  • AVG Volume (30 Days)
  • KDLY 810.1K
  • CERO 748.6K
  • Earning Date
  • KDLY 02-18-2025
  • CERO 02-20-2025
  • Dividend Yield
  • KDLY N/A
  • CERO N/A
  • EPS Growth
  • KDLY N/A
  • CERO N/A
  • EPS
  • KDLY N/A
  • CERO N/A
  • Revenue
  • KDLY $2,875,400.00
  • CERO N/A
  • Revenue This Year
  • KDLY N/A
  • CERO N/A
  • Revenue Next Year
  • KDLY N/A
  • CERO N/A
  • P/E Ratio
  • KDLY N/A
  • CERO N/A
  • Revenue Growth
  • KDLY N/A
  • CERO N/A
  • 52 Week Low
  • KDLY $0.65
  • CERO $1.70
  • 52 Week High
  • KDLY $5.25
  • CERO $1,238.00
  • Technical
  • Relative Strength Index (RSI)
  • KDLY N/A
  • CERO 32.71
  • Support Level
  • KDLY N/A
  • CERO $1.77
  • Resistance Level
  • KDLY N/A
  • CERO $2.22
  • Average True Range (ATR)
  • KDLY 0.00
  • CERO 0.34
  • MACD
  • KDLY 0.00
  • CERO 0.27
  • Stochastic Oscillator
  • KDLY 0.00
  • CERO 6.76

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

Share on Social Networks: